Amarin (AMRN +0.3%) says the USPTO has published notification of Notice of Allowance for an...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN +0.3%) says the USPTO has published notification of Notice of Allowance for an application to protect its heart pill Vascepa, which was approved in July by the FDA. The application is a continuation of its earlier patent, and broadens its claims by guaging the drugs effects against a subject's own baseline, as well as on a patient population basis. An earlier application granted last week had been guaged only against a placebo control group.